COVID-19 | Hetero, Cipla get nod to manufacture, market antiviral drug remdesivir

COVID-19 | Hetero, Cipla get nod to manufacture, market antiviral drug remdesivir Remdesivir, administered in the form of injection, should be given at a dose of 200 mg on day one followed by 100 mg daily for five days.

No comments:

Post a Comment